For the first time, Canada is unable to participate in a key clinical cancer trial because patients are not getting the best known treatment.Since most provinces don’t fund Avastin, a crucial drug in the fight against colorectal cancer, Canadian patients could not join a trial run by the National Cancer Institute in the United States, which is studying what drug is most effective with chemotherapy — Avastin or Erbitux — or if they work best given together.>>> Discuss This Story
